Latest News

Dow Jones Newswires: AstraZeneca’s Covid-19 vaccine gets EU approval for third doses

0

AstraZeneca PLC said Monday that its Covid-19 vaccine has been granted approval in the European Union as a third dose booster for adults.

The pharmaceutical company said that its Vaxzevria vaccine can now be used as a third dose booster in patients previously given a vaccine schedule of either Vaxzevria or other EU-approved vaccines.

“Although more than 65% of the global population has received at least one dose of a Covid-19 vaccine, there remains a significant challenge to ensure people receive both their primary vaccine schedule and third-dose booster, and healthcare professionals now have greater flexibility in their choice of vaccine,” AstraZeneca said.

Write to Jaime Llinares Taboada at jaime.llinares@wsj.com; @JaimeLlinaresT

Dow Jones Newswires: India steel stocks fall sharply after government announces export levy

Previous article

Forex Today: Crypto Firmer, US Dollar Continues Retreat

Next article

You may also like

Comments

Leave a reply

Your email address will not be published.

More in Latest News